Lyra Therapeutics (LYRA) PT Lowered to $10 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on Lyra Therapeutics (NASDAQ: LYRA) to $10.00 (from $11.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
